Genoscreen
- Company typePrivate
- Founded2001
- HeadquartersLille, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
Genoscreen firmographics
Firmographics- Name
- Genoscreen
- Legal name
- GenoScreen
- Website
- https://genoscreen.fr
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Genoscreen industry classification
Industry- Product category
- Genomic & Bioinformatics Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
- akta.pro secondary industries
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
Keywords
Where Genoscreen is headquartered
LocationHeadquarters
- HQ city
- Lille
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Genoscreen business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Genomic services: Sequencing, genotyping, and bioinformatics analysis services provided to clients including biotechs, pharmaceutical companies, research institutions, and agricultural companies
- Specialized diagnostic products: Deeplex product line (Deeplex Myc-TB, Deeplex Myc-Lep, Deeplex HelP) for molecular diagnostics of pathogens with integrated interpretation algorithms
- Training courses: Genomics technology training courses for researchers, biologists and doctors covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variants search
- Custom genomic services: Custom analytical protocols tailored to specific research objectives including oligonucleotide design, DNA/RNA extraction, PCR optimization, library preparation, and genomic analysis
- Regulatory compliance services: EFSA-compliant testing and dossier preparation for Novel Food, food enzymes, feed additives, and biofertilizers/biocontrol products
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Genoscreen product offering
Product offeringCore offering
GenoScreen is a B2B genomic and metagenomic services company that sells sequencing (NGS whole-genome, long-read, targeted, metagenomics, transcriptomics, and Sanger), genotyping (MIRU-VNTR, MLVA, SNP, microsatellite), and bioinformatics analysis to biotech, pharma, agro-industry/biosolutions, cosmetics, animal nutrition, academic, and clinical customers. It also markets the Deeplex line of targeted amplicon-based molecular diagnostic kits (Myc-TB, Myc-Lep, HelP) with integrated interpretation algorithms, and provides EFSA/FDA regulatory-dossier services (Novel Food, food/feed enzymes and additives, biofertilizers, biocontrol) backed by over 20 years of microorganism-study experience.
Product overview
GenoScreen is a genomic and metagenomic solutions company offering sequencing, genotyping, and bioinformatics services with specialized expertise in microbiology. The company provides a comprehensive portfolio including molecular diagnostic tests (Deeplex product line for mycobacteria and Helicobacter pylori identification and resistance prediction), next-generation sequencing services (whole genome sequencing, transcriptomics, metagenomics, targeted sequencing), genotyping services (MIRU-VNTR, SNP, microsatellite, microbial typing), microbiome analysis solutions (GenoBiome, skin microbiome, shotgun metagenomics, metatranscriptomics), and bioinformatics services (de novo assembly, genome annotation, variant detection, differential expression analysis). The company also offers regulatory compliance services for EFSA Novel Food, Feed Additives, Food Enzymes, and Biofertiliser/Biocontrol products, combining genomic analysis with dossier preparation for European market authorization. A strategic partnership with Staphyt extends capabilities into regulatory studies and field trials for agricultural biosolutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Deeplex Myc-TB A molecular diagnostic test for rapid identification of mycobacteria and prediction of resistance to 15 principal anti-tuberculosis antibiotics in 48 hours, based on deep amplicon sequencing technology; targeted at tuberculosis reference laboratories and clinical diagnostics programs.
- Deeplex Myc-Lep Deeplex Myc-Lep enables high-resolution genotyping and multidrug resistance prediction for Mycobacterium leprae directly from patient biopsies; targeted at clinical and reference laboratories working on leprosy diagnostics.
- Deeplex HelP A targeted deep amplicon sequencing test for Helicobacter pylori identification and resistance prediction; targeted at clinical microbiology laboratories and infectious disease reference centers.
- MIRU-VNTR (Mycobacterium tuberculosis genotyping) Mycobacterial Interspersed Repetitive Unit-Variable Number of Tandem Repeat (MIRU-VNTR) analysis for Mycobacterium tuberculosis genotyping and epidemiological tracking; targeted at public-health and tuberculosis reference laboratories.
- Brucella MLVA-16 Multiple Locus VNTR Analysis (MLVA-16) for Brucella species typing and surveillance; targeted at veterinary, food-safety, and reference laboratories.
- Whole Genome Sequencing (WGS) Complete genome sequencing using a hybrid long-read and short-read approach for high-quality genome assembly, including EFSA-compliant WGS for regulatory dossiers; targeted at biotech, agro-biosolutions, and academic customers needing high-quality microbial genomes.
- Transcriptomics (RNA sequencing) RNA sequencing service for whole-transcriptome analysis and differential gene expression studies; targeted at academic and industrial microbiology researchers.
- Metagenomics (NGS) Metagenomic sequencing for analysis of complex microbial communities from environmental and clinical samples; targeted at academic and industrial microbiome research programs.
- Targeted Sequencing Amplicon-based targeted sequencing for specific genomic regions of interest; targeted at customers studying defined microbial targets such as resistance genes.
- Sanger Sequencing Traditional Sanger sequencing service including molecular barcoding for sample identification; targeted at academic and industrial customers needing confirmation sequencing.
- Long Read Sequencing Long-read sequencing service for improved genome assembly and structural variant detection; targeted at biotech and academic customers needing high-contiguity assemblies.
- SSR Microsatellite Genotyping Microsatellite marker analysis for genetic characterization and strain typing; targeted at academic, agricultural, and food-safety customers.
- SNP Genotyping Single nucleotide polymorphism detection for genetic variation analysis; targeted at researchers and industrial customers analyzing genetic variation.
- Microbial Typing and Tracking Molecular typing services for microbial strain identification and epidemiological tracking; targeted at reference laboratories and public-health surveillance programs.
- Bioinformatics Analysis Services Comprehensive bioinformatics services covering de novo assembly, genome annotation, genome comparisons, mutation detection, differential gene expression analysis, and interactive bioinformatic reporting using proprietary interpretation algorithms; targeted at biotech, academic, and industrial customers outsourcing bioinformatics interpretation.
- GenoBiome (Microbiome Analysis) Proprietary microbiome analysis solution for characterization of microbial communities (bacteria, yeasts, fungi, algae) from various sample types, using culture-free molecular analysis; targeted at health, cosmetics, animal nutrition, and environmental customers.
- Skin Microbiome Analysis Specialized analysis of skin microbiota for cosmetic and dermatological research applications; targeted at cosmetic and dermatological research customers.
- Training Courses in Genomics Expert-led training courses covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variant searching; targeted at researchers, biologists, and doctors seeking hands-on genomics upskilling.
- EFSA Novel Food Dossier Services Comprehensive genomic characterization for EFSA Novel Food regulatory submissions, including Whole Genome Sequencing, antimicrobial resistance gene analysis, virulence factor screening, and dossier preparation; targeted at food and probiotic companies seeking Novel Food approval in Europe.
- Feed Additives & Enzymes Regulatory Services Regulatory support for feed additives and enzymes involving microorganisms, including genomic characterization for safety assessments; targeted at animal nutrition and feed-industry customers.
- Food Enzymes & Additives Regulatory Services Genomic analysis and dossier preparation for food enzyme and food additive regulatory approvals; targeted at food-industry customers needing EFSA compliance.
- Biofertiliser & Biocontrol Regulatory Services Regulatory compliance services for biofertilizers and biocontrol products, including genomic characterization for European market authorization; targeted at agro-industry and biosolutions customers.
Quantifiable outcome
- Predicts tuberculosis antibiotic resistance in 48 hours for 15 principal antibiotics
- +1 more outcomes
Companies that use Genoscreen
Customer profileSegments9 records
Ideal customer profiles2 records
Genoscreen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Genoscreen partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core and minor.
- StaphytcoreStrategic collaboration agreement combining GenoScreen's genomic technologies with Staphyt's regulatory studies and field trial capabilities. Partnership provides integrated services for agricultural product development, supporting the full product lifecycle from scientific validation to regulatory approval. Primarily targets agro-industry and biosolutions companies developing microbial products including biostimulants and biocontrol solutions subject to European standards.
- StaphytcoreStrategic collaboration to address growing regulatory and scientific complexity in the biosolutions sector. Integration of genomic data analysis with regulatory studies and field trials for microbial product development and regulation compliance in Europe.
- Institut Polytechnique UniLaSalleminorPartner in ADAGIO project (2019-2022) - a collaborative research initiative proposing innovative nutritional solutions (calcium butyrate + ellagitannins + fiber) to improve digestive health and comfort in monogastric farm animals.
- Sanluc InternationalminorPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
- ALGOFIT SolutionsminorPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
- Université de GandminorPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
- ADEMEminorFunding partner for BIMM-SOL project (2016-2018) - industrialization of procedures for analysis of molecular microbial bioindicators for qualitative biological diagnosis of soils. Also funded BioDISSPOL project for microbial biomarkers in chlorinated solvent-polluted site diagnosis.
- European Interreg France-Wallonie-VlaanderenminorEuropean funding program for ADAGIO project (2019-2022) on innovative nutritional solutions for monogastric farm animals
- National Tuberculosis Reference Centers (Africa/Europe)corePartners in DIAMA project (2016-2021) - evaluating and validating Deeplex Myc-TB test in Africa and Europe for rapid molecular diagnosis of tuberculosis and drug resistance prediction. Partners include centers from Belgium, Mali, UK, Guinea, Ethiopia, Congo, Rwanda, Senegal, Cameroon, and WHO.
- INSERMminorPartner in FLU-MICROBIOT project (2015-2018) studying the role of microbiotas and the gastrointestinal/pulmonary axis in respiratory diseases caused by influenza
- CNRSminorPartner in FLU-MICROBIOT project on gut-lung axis in influenza
- Institut Pasteur de LilleminorPartner in FLU-MICROBIOT project on gut-lung axis in influenza
- Université Fédérale du Minas GeraisminorInternational partner in FLU-MICROBIOT project on gut-lung axis in influenza
- BRGMminorPartner in BioDISSPOL project (2015-2018) for development of microbial biomarkers for diagnosis and monitoring of chlorinated solvent-polluted sites
- Université de StrasbourgminorPartner in BioDISSPOL project for microbial biomarkers in polluted site diagnosis
- INRAEminorPartner in MICROTYPE project (2014-2018) for global surveillance of infectious agents like Brucella through development of typing kits and databases
- BpiFranceminorFunding partner for FLU-MICROBIOT project (2015-2018) studying gut-lung axis in influenza
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Genoscreen competitors and assessment
Company assessmentEmerging players
- DNASense: Danish microbial genomics service provider focused on microbiome analysis, metagenomics, and microbial characterization for industrial and academic customers. Closely comparable niche positioning to GenoScreen's GenoBiome and microbial services.
Broad incumbents
- LGC Group (Biosearch Technologies): UK-based life sciences group offering genomic services, reference materials, and molecular biology reagents. Broad incumbent overlapping with GenoScreen in genomic services and genotyping for academic and industrial customers.
- Eurofins Genomics: European leader in genomic services including sequencing, genotyping, and bioinformatics for pharma, food, and academic clients. Operates at much larger scale than GenoScreen with broader portfolio and global footprint, making it the dominant broad incumbent in the same space.
- bioMérieux: French in vitro diagnostics leader with a strong microbiology portfolio including TB diagnostics and antimicrobial resistance testing. Comparable French domicile and infectious disease diagnostics overlap with GenoScreen's Deeplex products, though bioMérieux operates at vastly larger scale.
- Cerba Healthcare: French clinical diagnostics laboratory network offering specialty testing including infectious disease and molecular diagnostics. Comparable French base and clinical diagnostics adjacency, though focused on routine clinical testing rather than microbial genomics services.
Direct peers
- Macrogen: Global genomics services company providing NGS, Sanger, and bioinformatics with a strong microbial and clinical research focus. Direct peer in sequencing service menu and target customers, with significantly larger global scale.
- Microsynth: Swiss DNA sequencing and bioinformatics services provider serving pharma, academic, and industrial customers across Europe. Closely comparable in service model, sequencing menu (NGS, Sanger, long-read), and European SME customer profile.
- Novogene: Global NGS services provider with deep sequencing capacity, bioinformatics, and microbial/clinical applications. Direct competitor in genomic services for academic and industrial customers, with much larger scale.
- BaseClear: Dutch microbial genomics specialist offering sequencing, metagenomics, and bioinformatics with a strong microbial focus similar to GenoScreen. Directly comparable in microbiome/microbial services positioning and European academic-industrial customer base.
- Fasteris: Swiss genomics services company offering NGS, Sanger, and bioinformatics with a long-standing focus on European academic and biotech clients. Comparable service menu and similar scale to GenoScreen.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Genoscreen social profiles
Digital presenceGenoscreen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genoscreen leadership team
Management profileNumber of profiles
Profiles3 records
Genoscreen funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genoscreen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genoscreen
What does Genoscreen do?
GenoScreen is a B2B genomic and metagenomic services company that sells sequencing (NGS whole-genome, long-read, targeted, metagenomics, transcriptomics, and Sanger), genotyping (MIRU-VNTR, MLVA, SNP, microsatellite), and bioinformatics analysis to biotech, pharma, agro-industry/biosolutions, cosmetics, animal nutrition, academic, and clinical customers. It also markets the Deeplex line of targeted amplicon-based molecular diagnostic kits (Myc-TB, Myc-Lep, HelP) with integrated interpretation algorithms, and provides EFSA/FDA regulatory-dossier services (Novel Food, food/feed enzymes and additives, biofertilizers, biocontrol) backed by over 20 years of microorganism-study experience.
Is Genoscreen a public or private company?
Genoscreen is a private company. It is classified as unknown and is currently operating.
When was Genoscreen founded?
Genoscreen was founded in 2001. It employs 11 to 50 people.
Where is Genoscreen based?
Genoscreen is headquartered in Lille, France, in the Europe region.
How does Genoscreen make money?
Five revenue lines are on record. Genomic services are the primary driver. The others are specialized diagnostic products, training courses, custom genomic services and regulatory compliance services.
Who are Genoscreen's main competitors?
DNASense is listed as an emerging player. Broad incumbents are LGC Group (Biosearch Technologies), Eurofins Genomics, bioMérieux and Cerba Healthcare. Direct peers are Macrogen, Microsynth, Novogene, BaseClear and Fasteris.
Does Genoscreen have an API?
No public API is recorded for Genoscreen.
What industry is Genoscreen in?
Genoscreen's product category is Genomic & Bioinformatics Services. Its primary akta.pro industry code is HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support), with a secondary code of HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal). Its NAICS code is 6215 and its SIC code is 8071.